Oxybutynin Chloride Tablet, Extended Release
Product Images NDC 16729-319

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 16729-319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Oxybutynin Fig 1)

Figure 1 (Oxybutynin Fig 1)
FDA Label Image

Figure 2 (Oxybutynin Fig 2)

Figure 2 (Oxybutynin Fig 2)
FDA Label Image

Figure 3 (Oxybutynin Fig Study 1)

Figure 3 (Oxybutynin Fig Study 1)
FDA Label Image

Figure 4 (Oxybutynin Fig Study 2)

Figure 4 (Oxybutynin Fig Study 2)
FDA Label Image

Figure 5 (Oxybutynin Fig Study 3)

Figure 5 (Oxybutynin Fig Study 3)
FDA Label Image

Figure 8 (Oxybutynin Lab 10mg)

Figure 8 (Oxybutynin Lab 10mg)
Each tablet of this medication contains 10mg Oxybutynin Chloride USP and is for oral extended-release use. The package insert provides the usual dosage information. It is recommended to store the medication at room temperature, between 15 and 30 degrees Celsius. Protect from moisture and humidity and keep out of reach of children. The manufacturer is Accord Healthcare, Inc. located in Durham, NC. These tablets are manufactured by Infas Pharmaceuticals Umic in Ahmedbod, India. The medication is available in blister pack of 30 tablets and requires a prescription to purchase. The text doesn't contain information about the medical condition this medication is designed to treat.*
FDA Label Image

Figure 9 (Oxybutynin Lab 15mg)

Figure 9 (Oxybutynin Lab 15mg)
This is a description of a medication called Oxybutynin Chloride Extended-release tablets, USP. Each tablet contains 15 mg of the active ingredient. The dosage information can be found on the package insert. It should be stored at a temperature of 25°C (77°F) with excursions permitted between 15°C and 30°C (59°F to 86°F). The medication is manufactured by Infas Pharmaceuticals in India and distributed in the US by Accord Healthcare. The medication is only available with a prescription and comes in a package of 30 tablets. There is a caution to keep the medication away from children. The text also includes manufacturing and licensing information as well as instructions for storage.*
FDA Label Image

Figure 7 (Oxybutynin Lab 5mg)

Figure 7 (Oxybutynin Lab 5mg)
This is a medication called Oxybutynin Chloride in the form of an extended-release tablet, with a strength of 5mg per tablet. The recommended dosage is not stated in this text, and the package insert should be consulted for dosing information. The tablets should be stored at 25°C with permitted excursions between 15°C to 30°C. The medication should be kept away from moisture and humidity and out of reach of children. This product is manufactured by Infas Pharmaceuticals Umic, located in Ahmedbod, India, and is distributed by Aecord Healthcare Inc. based in Durham, NC. The National Drug Code (NDC) for this product is 16720-317-10, and it is available by prescription only. The other information on the text is inconclusive and irrelevant to the medication description.*
FDA Label Image

Chemical Structure (Oxybutynin Struc)

Chemical Structure (Oxybutynin Struc)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.